Black Rock Inc. Caribou Biosciences, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 6,947,820 shares of CRBU stock, worth $12.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,947,820

Previous 7,005,062 0.82%

Holding current value

$12.5 Million

Previous $36 Million 68.36%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$1.62 - $5.05 $92,732 - $289,072	-57,242 Reduced 0.82%	6,947,820 $11.4 Million
Q1 2024 May 10, 2024	SELL	$4.82 - $8.26 $305,616 - $523,733	-63,406 Reduced 0.9%	7,005,062 $36 Million
Q4 2023 Feb 13, 2024	BUY	$3.58 - $6.25 $3.52 Million - $6.15 Million	984,028 Added 16.17%	7,068,468 $40.5 Million
Q3 2023 Nov 13, 2023	BUY	$4.08 - $8.14 $5.38 Million - $10.7 Million	1,319,831 Added 27.7%	6,084,440 $29.1 Million
Q2 2023 Aug 11, 2023	BUY	$4.04 - $5.47 $40,585 - $54,951	10,046 Added 0.21%	4,764,609 $20.2 Million
Q1 2023 May 12, 2023	BUY	$4.3 - $7.78 $139,664 - $252,694	32,480 Added 0.69%	4,754,563 $25.2 Million
Q4 2022 Feb 13, 2023	BUY	$5.57 - $11.01 $1.36 Million - $2.69 Million	243,893 Added 5.45%	4,722,083 $29.7 Million
Q3 2022 Nov 14, 2022	BUY	$5.34 - $12.79 $2.29 Million - $5.48 Million	428,404 Added 10.58%	4,478,190 $47.2 Million
Q2 2022 Aug 12, 2022	BUY	$5.1 - $9.74 $3.73 Million - $7.12 Million	730,604 Added 22.01%	4,049,786 $22 Million
Q1 2022 May 12, 2022	BUY	$8.42 - $15.32 $13.1 Million - $23.8 Million	1,556,153 Added 88.27%	3,319,182 $30.5 Million
Q4 2021 Feb 10, 2022	BUY	$14.59 - $23.26 $8.48 Million - $13.5 Million	581,489 Added 49.21%	1,763,029 $26.6 Million
Q3 2021 Nov 09, 2021	BUY	$15.75 - $30.29 $18.6 Million - $35.8 Million	1,181,540 New	1,181,540 $28.2 Million

Others Institutions Holding CRBU

# of Institutions

135

Shares Held

52.6M

Call Options Held

148K

Put Options Held

70.7K

View Full List

About Caribou Biosciences, Inc.

Ticker CRBU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,840,800
Market Cap $110M
Description
Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...

More about CRBU

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account